Usefulness of CD200 in the differential diagnosis of SDRPL, SMZL, and HCL

Int J Lab Hematol. 2018 Aug;40(4):e59-e62. doi: 10.1111/ijlh.12824. Epub 2018 Apr 16.

Authors

R Favre¹, D Manzoni¹, A Traverse-Glehen^{2

3}, A Verney³, L Jallades^{1

3}, E Callet-Bauchu^{1

3}, P Sujobert^{1

3}, G Salles^{3

4}, L Baseggio^{1

3}

Affiliations

¹ Department of Hematologic Laboratory, Hospices Civils De Lyon/GHS, Lyon, France.
² Department of Anatomic Pathology, Hospices Civils De Lyon/GHS, Lyon, France.
³ Cancer Research Center of Lyon, INSERM 1052-CNRS UMR5286 « Clinical and Experimental Models of Lymphomagenesis », Lyon, France.
⁴ Department of Clinic Hematology, Hospices Civils De Lyon/GHS, Lyon, France.

PMID: 29659173
DOI: 10.1111/ijlh.12824

No abstract available

Publication types

Letter

MeSH terms

Antigens, CD / blood*
Diagnosis, Differential
Humans
Leukemia, Hairy Cell* / blood
Leukemia, Hairy Cell* / diagnosis
Leukemia, Lymphocytic, Chronic, B-Cell* / blood
Leukemia, Lymphocytic, Chronic, B-Cell* / diagnosis
Lymphoma, B-Cell, Marginal Zone* / blood
Lymphoma, B-Cell, Marginal Zone* / diagnosis
Neoplasm Proteins / blood*
Splenic Neoplasms* / blood
Splenic Neoplasms* / diagnosis

Substances

Antigens, CD
Neoplasm Proteins
antigens, CD200